5-Hydroxytryptamine-3 Antagonists: A New Class of Potent Antiemetics in Cancer Therapy

For many years nausea and vomiting have been recognized as side-effects of numerous chemotherapeutic regimens. The development of the useful new agent cisplatin, due with its powerful emetic effect, highlighted this patient problem.